Sale!

Beta Thalassemia Screening Prenatal Test Cost

Original price was: 1,610 د.إ.Current price is: 1,450 د.إ.

-10%

Beta Thalassemia is a blood disorder that reduces the production of hemoglobin, an iron-containing protein in red blood cells that carries oxygen to cells throughout the body. Individuals with thalassemia may develop anemia, leading to fatigue and other serious health problems. Given the genetic nature of this condition, prenatal screening is crucial for expecting parents, especially those with a family history of the disease or who are carriers of the thalassemia trait.

The Beta Thalassemia Screening Prenatal Test is a vital procedure offered at DNA Labs UAE, designed to detect the risk of the fetus inheriting beta thalassemia. This test is particularly recommended for couples at increased risk, providing them with essential information on their baby’s health and allowing for early intervention if needed.

The test involves collecting a small sample of the mother’s blood, which is then analyzed for the presence of mutations associated with beta thalassemia. It is a non-invasive procedure that poses no risk to the fetus.

The cost of the Beta Thalassemia Screening Prenatal Test at DNA Labs UAE is 1450 AED. This investment in prenatal health can offer peace of mind to expecting parents and help in the planning and management of potential health issues related to beta thalassemia. Early detection through this screening can be crucial in ensuring the well-being of both the mother and the child.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Beta Thalassemia Screening Prenatal Test

Test Name: Beta Thalassemia Screening Prenatal Test

Components: Sterile container / Sterile Normal Saline Container / EDTA Vacutainer (2ml)

Price: 1450.0 AED

Sample Condition: Amniotic fluid / Chorionic villi / Cord blood

Report Delivery: 3-4 days

Method: End Point PCR

Test Type: Genetics

Doctor: General Physician

Test Department: Pre Test Information

Beta Thalassemia Screening Prenatal Test can be done with a doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

Beta thalassemia screening is a prenatal test used to detect the presence of beta thalassemia, a genetic blood disorder. Beta thalassemia is characterized by reduced or absent production of hemoglobin, the protein in red blood cells that carries oxygen.

During the screening, a sample of the mother’s blood is taken and analyzed for the presence of specific genetic mutations associated with beta thalassemia. This can be done through various methods, such as DNA analysis or hemoglobin electrophoresis.

The screening is typically recommended for individuals of certain ethnic backgrounds, such as those of Mediterranean, Southeast Asian, or African descent, as these populations have a higher risk of carrying the beta thalassemia gene.

If the screening indicates a high risk of beta thalassemia in the fetus, further diagnostic tests, such as chorionic villus sampling or amniocentesis, may be recommended to confirm the diagnosis.

Early detection of beta thalassemia during pregnancy allows for appropriate medical management and counseling. Treatment options may include blood transfusions, iron chelation therapy, and, in severe cases, stem cell transplantation.

Test Name Beta Thalassemia Screening Prenatal Test
Components Sterile container / Sterile Normal Saline Container / EDTA Vacutainer (2ml)
Price 1450.0 AED
Sample Condition Amniotic fluid \/ Chorionic villi \/ Cord blood
Report Delivery 3-4 days
Method End Point PCR
Test type Genetics
Doctor General Physician
Test Department:
Pre Test Information Beta Thalassemia Screening Prenatal] can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

Beta thalassemia screening is a prenatal test used to detect the presence of beta thalassemia, a genetic blood disorder. Beta thalassemia is characterized by reduced or absent production of hemoglobin, the protein in red blood cells that carries oxygen.

During the screening, a sample of the mother’s blood is taken and analyzed for the presence of specific genetic mutations associated with beta thalassemia. This can be done through various methods, such as DNA analysis or hemoglobin electrophoresis.

The screening is typically recommended for individuals of certain ethnic backgrounds, such as those of Mediterranean, Southeast Asian, or African descent, as these populations have a higher risk of carrying the beta thalassemia gene.

If the screening indicates a high risk of beta thalassemia in the fetus, further diagnostic tests, such as chorionic villus sampling or amniocentesis, may be recommended to confirm the diagnosis.

Early detection of beta thalassemia during pregnancy allows for appropriate medical management and counseling. Treatment options may include blood transfusions, iron chelation therapy, and, in severe cases, stem cell transplantation.